This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
REVIEW UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
EAU 2016
- Prostate Cancer
- Bladder Cancer
- Renal Cancer
- Endourology
EAU 2016
Viewing 1-20 of 68 articles
EAU 2016: Degarelix is well tolerated and effective for the treatment of prostate cancer: Results from a phase III study in China - Poster
EAU 2016 Pathologic outcomes using different extended templates for lymph node dissection at radical prostatectomy - Poster Session Highlights
EAU 2016 The feasibility and safety evaluation of the pressure monitored air cystoscopy during active hematuria - Session Highlights
EAU 2016 Evaluation of a novel single use flexible ureteroscope - Session Highlights
EAU 2016 The new grasp-integrated flexible cystoscope (FC) Isiris (Coloplast®) for double J (DJ) removal: Evaluation of image quality, flow and flexibility - Session Highlights
EAU 2016 RIRS: Dusting vs fragmentation for renal stone
EAU 2016 Prospective European multicentre clinical results of kidney stone treatment using the Avicenna Roboflex URS robot - Session Highlights
EAU 2016 3D printing of renal tumors for preoperative simulation - Session Highlights
EAU 2016 Biodegradable drug-eluting stents: Targeting urothelial tumors of upper urinary tract - Session Highlights
EAU 2016 Prospective assessment of the adherent perinephric fat in partial nephrectomies - predictors and impact on peri-operative outcomes - Session Highlights
EAU 2016 Comparison of scoring systems used to predict stone free status after percutaneous nephrolithotomy: A single centre study with 208 cases - Session Highlights
EAU 2016 Ambulatory percutaneous nephrolithotomy: Single center prospective study - Session Highlights
EAU 2016 Assessing the volume-outcome relationship for PCNL in 2014: Analysis using national registry data of over 2000 cases - Poster Session Highlights
EAU 2016 Radium-223 (Ra-223) re-treatment (re-tx): Experience from an international, multicenter, prospective study in patients (pts) with castration-resistant prostate cancer and bone metastases (mCRPC) - Poster Session Highlights
EAU 2016 Randomized controlled trial of ultra mini percutaneous nephrolithotomy versus retrograde intrarenal surgery in the treatment of 10-30mm calculi - Session Highlights
EAU 2016 Percutaneous nephrolithotomy under X-ray control and totally ultrasound-guided percutaneous nephrolithotomy: The outcome comparison - Session Highlights
EAU 2016 Feasibility of supracostal access in supine percutaneous renal surgery - Session Highlights
EAU 2016: Do we really need to perform partial nephrectomy with zero ischemia? - Session Highlights
EAU 2016 Survival Outcomes in Octogenarian and nonagenarian patients treated with first-line androgen deprivation therapy for localized prostate cancer. - Session Highlights
EAU 2016 Long-term quality of life outcomes after active surveillance or curative treatment for prostate cancer - Session Highlights
1
2
3
4
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free